Compound ID,Uniprot,Target,PDB,Name,Smiles,DC50 (nM),Dmax (%),Assay (DC50/Dmax),Percent degradation (%),Assay (Percent degradation),"IC50 (nM, Protac to Target)","Assay (Protac to Target, IC50)","EC50 (nM, Protac to Target)","Assay (Protac to Target, EC50)","Kd (nM, Protac to Target)","Assay (Protac to Target, Kd)","Ki (nM, Protac to Target)","Assay (Protac to Target, Ki)","delta G (kcal/mol, Protac to Target)","delta H (kcal/mol, Protac to Target)","-T*delta S (kcal/mol, Protac to Target)","Assay (Protac to Target, G/H/-TS)","kon (1/Ms, Protac to Target)","koff (1/s, Protac to Target)","t1/2 (s, Protac to Target)","Assay (Protac to Target, kon/koff/t1/2)","IC50 (nM, Protac to E3)","Assay (Protac to E3, IC50)","EC50 (nM, Protac to E3)","Assay (Protac to E3, EC50)","Kd (nM, Protac to E3)","Assay (Protac to E3, Kd)","Ki (nM, Protac to E3)","Assay (Protac to E3, Ki)","delta G (kcal/mol, Protac to E3)","delta H (kcal/mol, Protac to E3)","-T*delta S (kcal/mol, Protac to E3)","Assay (Protac to E3, G/H/-TS)","kon (1/Ms, Protac to E3)","koff (1/s, Protac to E3)","t1/2 (s, Protac to E3)","Assay (Protac to E3, kon/koff/t1/2)","IC50 (nM, Ternary complex)","Assay (Ternary complex, IC50)","EC50 (nM, Ternary complex)","Assay (Ternary complex, EC50)","Kd (nM, Ternary complex)","Assay (Ternary complex, Kd)","Ki (nM, Ternary complex)","Assay (Ternary complex, Ki)","delta G (kcal/mol, Ternary complex)","delta H (kcal/mol, Ternary complex)","-T*delta S (kcal/mol, Ternary complex)","Assay (Ternary complex, G/H/-TS)","kon (1/Ms, Ternary complex)","koff (1/s, Ternary complex)","t1/2 (s, Ternary complex)","Assay (Ternary complex, kon/koff/t1/2)","IC50 (nM, Cellular activities)","Assay (Cellular activities, IC50)","EC50 (nM, Cellular activities)","Assay (Cellular activities, EC50)","GI50 (nM, Cellular activities)","Assay (Cellular activities, GI50)","ED50 (nM, Cellular activities)","Assay (Cellular activities, ED50)","GR50 (nM, Cellular activities)","Assay (Cellular activities, GR50)",Degradation Identification,Degradation Identification new 1,Degradation Identification new 2,Article DOI,Molecular Weight,Exact Mass,logP,logS,Heavy Atom Count,Ring Count,Hydrogen Bond Acceptor Count,Hydrogen Bond Donor Count,Rotatable Bond Count,Topological Polar Surface Area,Molecular Formula,InChI,InChI Key,E3 Ligase,Degradation activity,Degradation activity,Degradation Assay
1,Q9NPI1,BRD7,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,>1000 nM,~20%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor,Bad,Bad,10.1021/acs.jmedchem.8b01413,953.176,952.4516966,3.82,-5.68,68,7,15,3,19,189.92,C50H64N8O9S,"InChI=1S/C50H64N8O9S/c1-32-45(68-31-53-32)34-10-8-33(9-11-34)25-52-47(61)41-24-36(59)27-58(41)49(63)46(50(2,3)4)54-44(60)30-67-21-20-66-19-18-56-14-16-57(17-15-56)29-40-42(64-6)22-35(23-43(40)65-7)39-28-55(5)48(62)38-26-51-13-12-37(38)39/h8-13,22-23,26,28,31,36,41,46,59H,14-21,24-25,27,29-30H2,1-7H3,(H,52,61)(H,54,60)/t36-,41+,46-/m1/s1",RPMQBLMPGMFXLD-PDUNVWSESA-N,VHL,"HeLa 4h, 20%","HeLa 16h, 12%",% BRD7 degradation in HeLa cells after 4/16 h treatment at 1 ??M
1,Q9H8M2,BRD9,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,>1000 nM,~30%,,,,,,,,15,ITC,,,-10.7,-12.5,1.8,ITC,,,,,,,,,33/24,ITC/FP,,,-10.2,-15.2,4.9,ITC,,,,,,,,,73/98,ITC/FP,,,-9.7,-6.4,-3.3,ITC between VHL and BRD9-BD:PROTAC,,,,,,,,,,,,,,,Poor,Bad,Bad,10.1021/acs.jmedchem.8b01413,953.176,952.4516966,3.82,-5.68,68,7,15,3,19,189.92,C50H64N8O9S,"InChI=1S/C50H64N8O9S/c1-32-45(68-31-53-32)34-10-8-33(9-11-34)25-52-47(61)41-24-36(59)27-58(41)49(63)46(50(2,3)4)54-44(60)30-67-21-20-66-19-18-56-14-16-57(17-15-56)29-40-42(64-6)22-35(23-43(40)65-7)39-28-55(5)48(62)38-26-51-13-12-37(38)39/h8-13,22-23,26,28,31,36,41,46,59H,14-21,24-25,27,29-30H2,1-7H3,(H,52,61)(H,54,60)/t36-,41+,46-/m1/s1",RPMQBLMPGMFXLD-PDUNVWSESA-N,VHL,"HeLa 4h, 19%","HeLa 16h, 30%",% BRD9 degradation in HeLa cells after 4/16 h treatment at 1 ??M
2,Q9NPI1,BRD7,,,COC1=CC(C2=CN(C)C(=O)C3=CN=CC=C23)=CC(OC)=C1CN1CCN(CCOCCOCCOCCOCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCC2=CC=C(C3=C(C)N=CS3)C=C2)C(C)(C)C)CC1,>1000 nM,~27%,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Poor,Bad,Bad,10.1021/acs.jmedchem.8b01413,1041.282,1040.504126,3.84,-5.73,74,7,17,3,25,208.38,C54H72N8O11S,"InChI=1S/C54H72N8O11S/c1-36-49(74-35-57-36)38-10-8-37(9-11-38)29-56-51(65)45-28-40(63)31-62(45)53(67)50(54(2,3)4)58-48(64)34-73-25-24-72-23-22-71-21-20-70-19-18-60-14-16-61(17-15-60)33-44-46(68-6)26-39(27-47(44)69-7)43-32-59(5)52(66)42-30-55-13-12-41(42)43/h8-13,26-27,30,32,35,40,45,50,63H,14-25,28-29,31,33-34H2,1-7H3,(H,56,65)(H,58,64)/t40-,45+,50-/m1/s1",NGWWVKZONFCNQP-SHPBXJAASA-N,VHL,"HeLa 4h, 19%","HeLa 16h, 27%",% BRD7 degradation in HeLa cells after 4/16 h treatment at 1 ??M
